Tercica, Inc. - Financial and Strategic Analysis Review - companiesandmarkets.com adds new report

companiesandmarkets.com

2009-04-23 16:11:04 - Tercica, Inc. - Financial and Strategic Analysis Review - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Tercica,-Inc ..

Tercica, Inc. - Financial and Strategic Analysis Review

Summary

Tercica, Inc. (Tercica) is engaged in the development and commercialization of new therapeutics for the metabolic health and endocrine markets. Its major products consist of novel biologic products such as Increlex and Somatuline Depot. Its first product Increlex is developed for the treatment of children with short stature due to severe primary IGF-1

 

 

deficiency IGFD. Its second product Somatuline Depot is used for the long treatment of patients with acromegaly. The company is also engaged in the research and development of growth hormone/IGF-1 combination product candidates with Genentech, Inc. It is headquartered in California, United States and has 126 employees.

This report presents an in-depth business, strategic and financial analysis of Tercica, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and views on the company.

Scope

-The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.

-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.

-The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.

-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

-A quick “one-stop-shop” to understand the company.

-Enhance business/sales activities by understanding customers’ businesses better.

-Get detailed information and financial & strategic analysis on companies operating in your industry.

-Identify prospective partners and suppliers – with key data on their businesses and locations.

-Capitalize on competitors’ weaknesses and target the market opportunities available to them.

-Compare your company’s financial trends with those of your peers / competitors.

-Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.